CELEX ONCOLOGY INNOVATIONS LIMITED
Company number 11085607 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£3,849,744
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-11-28
- Employees
- 4 (2024 accounts · was 3 in 2023)
- Registered office
- 101 New Cavendish Street, 1st Floor South, London, United Kingdom, W1W 6XH
- Postcode
- W1W 6XH
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-04-05
- Next due by
- 2027-04-19
Nature of business (SIC)
- 21100 Manufacture of basic pharmaceutical products
Officers 3 current · 6 resigned
Bhavani, Dr HARIMOHAN
Director
MR Carsten Kronsbjerg FALTUM
Director
MR Laurence John COHEN
Director
Contact details
- Website
- celexoncology.com
Among its peers
Top 10%
by shareholders' funds, of 31 similar companies in W
2nd largest employer among its local peers (4 staff).
Trading since 2017.
No.2 of the largest manufacture of basic pharmaceutical products companies in London →
Competitors London
-
5. VERANYO LTD
This company ranks 2 among manufacture of basic pharmaceutical products in London.
The class of 2017
29%
of the 636,553 companies incorporated in 2017 are still active today; 66% have since been dissolved.
A fact about the year, not a forecast for this company.